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The mechanism of action of S1P is quite complex, as this bioactive lipid is an intracellular mediator as well as a receptor ligand (14) . Indeed, intracellular S1P regulates gene transcription by directly affecting histone deacetylase activity (25) or NF-B signaling (62) . S1P is released in the extracellular environment through various transporters (42) , where it acts by autocrine/paracrine mechanisms as a ligand of five distinct S1P receptors, S1P [1] [2] [3] [4] [5] . S1P receptors are coupled to specific GTPbinding proteins that activate distinct signaling pathways (38, 39, 52, 61) .
Three S1P receptor subtypes (S1P [1] [2] [3] ) are expressed in adult skeletal muscle. S1P 1 and S1P 3 receptors are localized both in the cell and nuclear membrane of adult fibers and in the neuromuscular junction (69) . S1P 1 and S1P 3 are expressed by quiescent satellite cells of adult muscle, whereas S1P 2 is only transiently expressed in activated satellite cells (13, 19, 26) . The molecular mechanisms for the action of S1P and the role of individual receptors in skeletal muscle are still not well understood. Our previous results, using agonist and antagonist of S1P receptors, indicate that S1P 1 and S1P 3 display opposite actions in controlling the growth of regenerating fibers in rat soleus muscle (13) . Moreover, S1P 2 plays a critical role during the early phases of muscle regeneration; the lack of S1P 2 resulted in a delay of regenerating muscle fiber growth (24, 36) . Recently, it has been demonstrated in vivo that in the absence of S1P 3 , acute regeneration is enhanced both after a single and repeated cycles of muscle injury (19) . Finally, in vitro experiments demonstrated that supplementation of S1P attenuates the development of extensor digitorum longus (EDL) muscle fatigue, induced by low-frequency repeated short tetani (11) , indicating that S1P signaling is involved in this important property of skeletal muscle, even though the putative role of S1P receptors has not yet been investigated in detail.
A striking characteristic of skeletal muscle is plasticity, i.e., the ability to adapt its mass, fiber type composition, metabolism, and performance to different functional requests. Activity plays a fundamental role in controlling skeletal muscle characteristics. Increased activity, such as strength exercise and functional overload, produces the enlargement of muscle fiber (hypertrophy), whereas muscle disuse, such as bed rest, spinal cord injury, denervation, immobilization, and microgravity, induces atrophy, characterized by the reduction of muscle mass (58) . Muscle atrophy occurs when protein degradation sur-passes protein synthesis. Two major pathways regulate protein degradation, the ubiquitin-proteasome system and the autophagy-lysosome pathway (55) . The IGF-1/Akt/mTOR/ FoxOs signaling pathway positively regulates muscle growth (59) , whereas the myostatin-SMAD2/3 pathway acts as a negative regulator (32) . The IGF-1-dependent phosphorylation of Akt, also known as PKB, stimulates mammalian target of rapamycin (mTOR) and protein synthesis and prevents the nuclear localization and transcriptional activity of Forkhead box O (FoxO), which is critical for the atrophy process (33) . The reduced activity of the Akt pathway, observed in various models of muscle atrophy, leads to decreased protein synthesis and a marked increase in nuclear FoxO, where it stimulates the expression of diverse atrophy genes (57) . However, it is worth reporting that recent evidence indicates that denervation may be Akt independent (37) . In any case, nuclear FoxO mainly stimulates the expression of two atrophy-specific E3 ubiquitin ligases, atrogin-1 and MuRF1, which direct the ubiquitination and degradation of muscle proteins (4) . Moreover, FoxO proteins induce the expression of many autophagy (such as, LC3-II, p62, and Beclin1) and lysosomal genes (70) . In this respect, an autophagy-mediated removal of mitochondria (mitophagy) as well as a mitochondrial-mediated apoptosis has been observed during denervation (46, 60) . Additional key players are active during muscle atrophy, such as the NF-B pathway, myogenin, and the peroxisome proliferative activated receptor-␥ coactivator 1␣ (PGC-1␣) (17, 63) . In particular, PGC-1␣, master regulator of mitochondria biogenesis (34) , is indicated to be involved in the atrophy-related mitochondrial dysfunction and to affect the development of muscle atrophy both in soleus and EDL muscles (5, 6) .
Injury of motor nerve causes the progressive atrophy of muscle fibers, fiber type-specific myosin heavy chain (MyHC) transformation, and impairment of functional properties (41) . We demonstrated that exogenous application of S1P counteracts the denervation atrophy of rat soleus, a slow-twitch muscle, whereas the depletion of the extracellular lipid with a specific anti-S1P monoclonal antibody accelerated the atrophy caused by denervation of mouse soleus. In addition, infusion with S1P attenuated the slow-to-fast transformation attributable to denervation in soleus muscle of rat (69) .
In the present work, by using S1P 3 -null mice, we explored the functional role of S1P 3 on skeletal muscle. We investigated the morphological and contractile properties of the fast-twitch skeletal muscle EDL and analyzed the effects of denervation on atrophy development of the transgenic muscle. Overall, the study demonstrates that S1P 3 ablation affects the physiological properties of EDL muscle, its fiber type composition, and the expression of residual S1P receptors. The absence of S1P 3 makes EDL muscle more sensitive to fatigue and slows down atrophy development in the denervated muscle. Moreover, exogenous S1P supplementation affects fatigue development of S1P 3 -null EDL.
METHODS
The Italian Health Ministry approved all animal experimental protocols. C57BL/6J (wild-type) and S1P 3-null mice, generated by Jerold Chun, Scripps Institute (La Jolla, CA) (27) and kindly provided by Dr. Bodo Levkau, University of Essen, Germany (the genotype of S1P 3-null mouse was confirmed by PCR), were fed ad libitum with standard chow/water diet and kept under a 12-h:12-h light/dark cycle in an air-conditioned room. Three-month-old male mice were used.
EDL muscle contractile properties. The experiments were performed in vitro in a vertical muscle apparatus (300B, Aurora Scientific) containing a Ringer solution of the following composition: 120.00 mM NaCl, 4.70 mM KCl, 2.50 mM CaCl 2, 3.15 mM MgCl2, 1.30 mM NaH 2PO4, 25 .00 mM NaHCO3, 11.00 mM glucose, and 30.00 M D-tubocurarine, pH 7.2-7.4, 30°C, bubbled with 95% O 2-5% CO2. Muscles were stretched to the optimal length (i.e., the length that allowed maximal tension development in response to a single pulse) and electrically stimulated by two parallel electrodes, with supramaximal pulses (0.5-ms duration) delivered by a Grass S44 electronic stimulator through a stimulus isolation unit (Grass SIU5). Muscle response was recorded through an isometric force transducer (Grass-FT03) connected to an AT-MIO 16AD acquisition card (National Instruments). Data were analyzed by the specific module of the National Instruments LabView software (23) . Contraction and halfrelaxation times of the twitch were measured. Twitch and tetanic tensions were normalized to the muscle wet weight (specific tension, N/g). Force-frequency curve was determined by stimulating EDL muscle at 1, 30, 45, 60, 75, 90, 110, 130 , and 150 Hz. Muscles were weighed at the end of each experiment.
Muscle fatigue. Small intact bundles of about 10 -20 fibers from the EDL or 5-10 fibers from flexor digitorum brevis (FDB) were mechanically dissected in Tyrode solution, of the following composition: 121.00 mM NaCl, 5.00 mM KCl, 1.80 mM CaCl 2, 0.50 mM MgCl2, 0.40 mM NaH2PO4, 24.00 mM NaHCO3, 5.50 mM glucose, 0.10 mM EDTA, and 0.05% DMSO (8, 45) . The solution was bubbled with 5% CO2-95% O2, which gave a pH of 7.4. The experiments were performed at 24°C in control solution supplemented or not with 1 M S1P. S1P was prepared by dilution of 2 mM stock solution in DMSO that was used as vehicle control of S1P. The use of small bundles of fibers (called fibers in this paper, for simplicity) offers ideal mechanical conditions for fast stiffness measurements. Small aluminum clips were attached to tendons as close as possible to the fiber ends (50 -100 m) to mount horizontally the fibers in an experimental chamber between the lever arms of a homemade capacitance force transducer (resonance frequency 15-30 kHz) and of an electromagnetic motor (minimum stretch time 150 s) used to apply fast length changes to the fibers. Fibers were electrically stimulated with bipolar stimuli (0.5-ms duration and 1.5 times threshold strength) applied by means of two parallel platinum-plate electrodes. The fiber length was adjusted to that giving maximum tetanic force (P0) corresponding to a mean sarcomere length of about 2.5-2.6 m. Mean clip to clip fiber length (lf) was 1,131 Ϯ 27 m (n ϭ 16) in FDB wild-type and 1,217 Ϯ 41 m (n ϭ 20) in FDB S1P3-null mice; 6,317 Ϯ 160 m (n ϭ 10) and 6,386 Ϯ 237 m (n ϭ 8) in EDL wild-type and S1P3-null mice, respectively. Resting sarcomere and fiber length were measured under ordinary light illumination using a microscope and on digital images acquired by a video camera (Infinity Camera, Lumenera) using image-processing software. Sarcomere length was measured by counting 10 consecutive sarcomeres on a calibrated scale on the acquired images. Stimuli and fiber length changes were controlled by custom-written software (LabView), which was also used to record force and length at sampling speed up to a maximum of 200 kHz.
Before the start of each experiment, fibers were maintained at optimal sarcomere length for 15 min in control solution without electrical stimulation. Twitch and tetanic tension (control tetanic stimulation: 70-Hz frequency, 300-ms duration, and 90 Hz, 250 ms for FDB and EDL, respectively) levels were measured. Tetani were given at an interval of 2 min for a period of equilibration of about 8 -12 min, in which P0 remained stable. If P0 decreased by Ͼ15%, the fibers were discarded. In the experiments with S1P supplementation, a viability test was made before and after 30 min of incubation with 1 M S1P. Untreated or treated fibers where subjected to a fatigue protocol consisting of 105 tetani (70 Hz, 300 ms every 1.5 s, for FDB; 90 Hz, 350 ms every 3 s, for EDL). Recovery from fatigue was followed for 30 min in EDL or 60 min in FDB by applying tetani with the same characteristics every 2 min.
Stiffness. To estimate the number of attached crossbridges we measured fiber stiffness (43, 45) by applying small (about 0.2% l f) sinusoidal length changes (dl) to one end of the activated fibers and measured the resulting force oscillations (dp) at the other end. The oscillation frequency was 2.5 and 6.5 kHz for EDL and FDB, respectively. The measurements and calculations were made as previously reported in detail (43, 45) . Briefly, fiber stiffness was calculated as the ratio dp/dl at any tension over dp/dl measured at P 0. Stiffness data presented here refer to the relative changes of this ratio during tetanus rise and during fatigue respect to the values measured at plateau before the fatigue.
Surgical procedures. All surgical procedures were performed in a single session under general anesthesia, carried out by the intraperitoneal injection of tiletamine and zolazepam (7 mg/kg, Virbac, Carros) and xylazine (14 mg/kg, Bayer). The sciatic nerve was cut monolaterally at the level of trochanter. About 0.5-1.0 cm of the peripheral nerve stump was removed to avoid reinnervation and obtain a permanent denervation of the lower hind limb. Mice were euthanized 7 or 14 days after denervation by neck dislocation. Denervated and contralateral EDL muscles were used for functional, biochemical, and molecular studies, whereas denervated and contralateral tibialis anterior (TA) muscles were used for mitochondrial analyses.
Histological and immunofluorescence analysis. Muscles were isolated and quickly frozen in liquid nitrogen in a slightly stretched position. Serial cross sections (8 m thick) were cut in a cryostat microtome (Slee) set at Ϫ24 Ϯ 1°C. Hematoxylin-eosin (HE) and succinate dehydrogenase (SDH) staining were performed on transverse muscle sections to examine the general morphology and overall mitochondrial content (54) . To better evaluate the mitochondrial content, SDH staining images were processed with Adobe Photoshop by setting the SDH intensity of individual fibers on an arbitrary 0 -255 grayscale. Then fibers with similar SDH intensity were assembled in ten discrete groups. Laminin staining was carried out to determine the cross-sectional area (CSA) of individual fibers (69) . Muscle sections were incubated for 1 h at 37°C with the polyclonal antibody specific for laminin (L9393, Sigma) diluted 1:150 in 5% fetal bovine serum. Laminin was revealed with an anti-rabbit FITC-labeled secondary antibody (F0382, Sigma) diluted 1:200 in PBS incubated for 1 h at 37°C. Muscle sections were examined in a Leica RD100 fluorescence microscopy equipped with a digital camera. Muscle fiber CSA was measured on digital photographs by the ImageJ NIH software. More than 600 fibers per muscle were evaluated.
Western blotting and SDS-PAGE analysis. Western immunoblotting was performed on muscle fragments dissolved in SDS-PAGE buffer supplemented with Complete protease inhibitors cocktail (Roche) and phosphatase inhibitor cocktail (Sigma). Muscle lysates (25-30 g each) were electrophoresed on 10% SDS-PAGE gels. Electroblotting was performed as previously described (69) . Nitrocellulose filters were probed with the selected primary antibody incubated overnight at 4°C at the conditions described above.
The following rabbit polyclonal antibodies were used: PhosphoAkt (Cell Signaling Technology; 1:2,000 in 5% BSA and 0.1% Tween-20 in TBS), Akt (Cell Signaling Technology; 1:500 in 5% BSA and 0.1% Tween-20 in TBS), Atrogin-1 (ECM Biosciences; 1:1,000 in 5% low-fat milk, 0.04% Tween-20 in TBS), MuRF1 (ECM Bioscences; 1:500 in 5% low-fat milk, 0.04% Tween-20 in TBS), FoxO3 (Cell Signaling Technology; 1:250 in 5% low-fat milk, 0.1% Tween-20 in TBS), P-FoxO3, (Cell Signaling Technology; diluted 1:500 in 5% low-fat milk, 0.1% Tween-20 in TBS), cytochrome c (Cell Signaling Technology; 1:1,000 in 5% low-fat milk, 0.1% Tween-20 in TBS), GAPDH (GenTex; 1:5,000 in 2% BSA, 0.2% Tween-20 in TBS), sarcomeric actin (Sigma; 1:5,000 in 5% low-fat milk, 0.2% Tween-20 in TBS), LC-3 and P62 (Sigma; 1:1,000 in 5% low-fat milk, 0.1% Tween-20 in TBS), PGC-1␣ (Abcam; 1:1,000 in 5% low-fat milk, 0.1% Tween-20 in TBS). The secondary antibody utilized was an anti-rabbit peroxidase-conjugated antibody (Chemicon) diluted 1:5,000 in the same buffer as the cognate primary antibody and incubated for 1 h.
Moreover, the following mouse monoclonal antibodies were used: myogenin (F5D, Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA) 1:100 in 10% low-fat milk, 0.1% Tween-20 in TBS, ␣-actinin (EA-53, Sigma) 1:1,000 in 5% low-fat milk, 0.2% Tween-20 in TBS, incubated for 1 h. The secondary antibody was an anti-mouse peroxidase-conjugated antibody (Dako) at 1:10,000 dilution (in the same buffer as the cognate primary antibody), incubated for 1 h. Visualization of reaction bands was performed either by tetramethylbenzidine staining or by enhanced chemiluminescence (Amersham Pharmacia Biotech). Signal intensities were evaluated by densitometry.
Analysis of whole-muscle MyHC isoforms was performed by the SDS-PAGE method of Talmadge and Roy, as previously described (12) . Small muscle fragments were solubilized in SDS-PAGE sample buffer (62.5 mM Tris, pH 6.8, 2.3% SDS, 5% 2-mercaptoethanol, 10% glycerol). Muscle protein samples (10 g each) were electrophoresed on 8% SDS-PAGE slab gels. MyHC protein bands were revealed by Coomassie brilliant blue staining. MyHC isoform percentage composition was determined by densitometry of gels by using a Bio-Rad Imaging Densitometer (GS-670).
Cell fractionation. Mouse muscles were homogenized on ice in 15 volumes of 10 mM Tris·HCl, 0.25 M sucrose, 0.2 mM EDTA, pH 7.8, containing protease inhibitor cocktail. The homogenates were centrifuged at 2,000 g for 8 min at 4°C. Pellets contained myofibrils, whereas the supernatant contained mitochondrial, cytosolic, and membrane proteins. The supernatant was then centrifuged at 12,000 g for 15 min at 4°C. The pellet contained mitochondria, whereas the supernatant contained cytosolic and membrane proteins. The mitochondrial fraction was resuspended in 10 mM Tris·HCl, 0.25 M sucrose, 0.2 mM EDTA, pH 7.8 (with protease inhibitor cocktail) and subjected repeatedly (3-4 times) to centrifugation at 12,000 g for 15 min at 4°C. After the last centrifugation, the pellet was snap frozen in liquid nitrogen and kept at Ϫ80°C for future analysis (18) .
Real-time PCR. Total RNA (1 g), extracted with TRI Reagent from EDL, was reverse transcribed using the High-Capacity cDNA Reverse Transcription kit, according to the manufacturer's instructions (Life Technologies). The quantification of S1P receptor (S1P1, S1P2, and S1P3) mRNA level was performed by real-time PCR employing TaqMan Gene Expression Assays (S1P1 Mm00514644_m1; S1P2 Mm01177794_m1; S1P3 Mm00515669_m1). Each measurement was carried out in triplicate, using the automated ABI Prism 7700 Sequence Detector System (Life Technologies), as described previously (15) by simultaneous amplification of the target sequence together with the housekeeping gene 18S rRNA. Results were analyzed by ABI Prism Sequence Detection Systems software, version 1.7 (Life Technologies).
The 2
Ϫ⌬⌬Ct method was applied as a comparative method of quantification (35) , and data were normalized to ribosomal 18S RNA expression.
Statistical analysis. All values are means Ϯ SE. Comparisons of mean values were performed after ANOVA and the Newmann-Keuls post hoc test. In the real-time PCR experiments, results are expressed as means Ϯ SE of fold changes according to the 2 -⌬⌬Ct method, utilizing 18S rRNA as housekeeping and each S1P receptor in wildtype innervated EDL as calibrator. Statistical significance of real-time PCR data was assessed with two-way ANOVA followed by Bonferroni's post hoc test. In all the statistical analyses, differences were considered significant at the P Ͻ 0.05 level. 3 -null EDL muscle. To examine the role of S1P 3 and its downstream signaling in modulating muscle properties, we utilized transgenic mice lacking S1P 3 (27, 28) . The absence of S1P 3 apparently did not affect the normal growth of mice, as the body weight of 3-mo-old male S1P 3 -null mice was similar to that of age-matched wild-type controls (Fig. 1A) . Moreover, the muscle mass and the ratio between muscle mass and body weight of fast-twitch EDL isolated from S1P 3 -null mice were similar to that of wild-type muscle (Fig. 1A) . Coherently, the mean CSA of S1P 3 -null muscle fibers was similar to that of wild-type (Fig. 1A) .
RESULTS

Characterization of S1P
Morphology of EDL muscle did not show evident differences between wild-type and S1P 3 -null mice (Fig. 1B) . However, SDH staining, an estimate of mitochondria content, showed a higher intensity in the S1P 3 -null EDL compared with wild-type (Fig. 1, C and D) . Coherently, the amount of cytochrome c in the total muscle homogenate from S1P 3 -null EDL was larger (13.2 Ϯ 1.6 a.u., n ϭ 11) than that in wild-type (8.1 Ϯ 1.2, a.u., n ϭ 7, P Ͻ 0.05).
Body mass (g) A: body mass (n ϭ 24), muscle mass (n ϭ 11), muscle-to-body mass ratio (n ϭ 11), and muscle fiber cross-sectional area (CSA) (n ϭ 11) of 3-mo-old male mice from wild-type (WT) and S1P3-null mice. B: hematoxylin-eosin of EDL muscle from WT and S1P3-null mice. Bar ϭ 20 m. C: succinate dehydrogenase (SDH) staining of EDL whole muscle from WT and S1P3-null mice. Bar ϭ 100 m. D: SDH staining intensity of EDL muscle fibers from WT and S1P3-null mice. See METHODS for details. E: myosin heavy chain (MyHC) isoform composition in EDL muscle from WT and S1P3-null mice. Data are reported as means Ϯ SE. For each group, 6 -10 experiments were carried out. F: expression of S1P1 and S1P2 receptor transcripts in EDL muscle isolated from WT and S1P3-null mice. S1P receptors in each S1P3-null muscle were measured by real-time PCR and compared with that in wild-type muscles. Results are expressed as fold changes according to the 2 -⌬⌬Ct method, utilizing S1P1 or S1P2 genes in wild-type muscle as calibrator. Data are reported as means Ϯ SE of 3 independent experiments performed in triplicate. *P Ͻ 0.05 compared with WT.
To evaluate whether the absence of S1P 3 may affect the overall muscle phenotype, the expression level of MyHC isoforms was analyzed by SDS-PAGE. The densitometric analysis of MyHC composition showed no major differences between wild-type and S1P 3 -null EDL except for a slightly higher content in the slow type 1 MyHC isoform in the transgenic muscle (Fig. 1E) .
We next examined whether the absence of S1P 3 affects the expression level of the S1P receptors physiologically expressed in skeletal muscles (13, 26) . We quantitated, by real-time PCR, the transcript level of S1P 1 and S1P 2 receptors in EDL muscle. The data show that the expression of S1P 1 and S1P 2 was enhanced in the S1P 3 -null EDL (Fig. 1F) .
We then analyzed the contractile properties of EDL muscle deprived of S1P 3 receptor. Twitch tension of S1P 3 -null EDL was significantly smaller (P Ͻ 0.05) compared with wild-type (Fig. 2, A and C) , whereas time-to-peak tension (15.7 Ϯ 0.9 vs. 15.0 Ϯ 0.7 ms) and half-relaxation time (15.3 Ϯ 1.7 vs. 11.7 Ϯ 1.2 ms) were similar ( Fig. 2A) . The tetanic tension of S1P 3 -null EDL was not significantly different from that of wild-type (Fig.  2, B and C) . The force/frequency curve of S1P 3 -null EDL shifted to the right, with significantly reduced tension at low stimulation frequencies (Fig. 2D) .
Moreover, we measured the resistance to and recovery from fatigue in muscle fibers isolated from wild-type and the S1P 3 -null EDL (Fig. 3, A and B) . At the end of the fatigue protocol, in wild-type fibers, force decreased to 0.42 Ϯ 0.09 P 0 , whereas S1P 3 -null fibers were largely (P Ͻ 0.05) more fatigable than wild-type fibers starting from the 42nd tetanus. All S1P 3 -null fibers endured the full fatiguing stimulation protocol, but the mean force in the last tetanus was 0.22 Ϯ 0.03 P 0 . After 2 min of resting, tetanic force reached 0.56 Ϯ 0.10 and 0.30 Ϯ 0.03 of the prefatigue value, respectively in wild-type and in S1P 3 -null fibers (Fig. 3, A and B) . Both wild-type and S1P 3 -null fibers reached the maximum force recovery value in a few minutes after the end of fatigue and then remained almost constant. However, at the end of the recovery period, the tetanus force was significantly higher (P Ͻ 0.05) in wild-type fibers (0.61 Ϯ 0.07 P 0 ) compared with that of S1P 3 -null fibers (0.35 Ϯ 0.05 P 0 ) (Fig. 3, A and B) . As shown in Fig. 3C , the average time course of stiffness drop during fatigue was similar to tension decrease in both wild-type and S1P 3 -null fibers, reaching 0.60 Ϯ 0.07 at the end of the fatigue protocol and 0.39 Ϯ 0.03 P 0 of the prefatigue value.
We then examined the effects of S1P supplementation on fatigue responses of wild-type and S1P 3 -null EDL fibers. In the resting state, twitch properties and tetanic tension of wild-type and S1P 3 -null EDL were not affected by the treatment. S1P supplementation did not influence fatigue development and recovery of wild-type EDL (Fig. 3A) . Vice versa, in the presence of S1P, fatigue development of S1P 3 -null EDL fibers was significantly reduced, making the fatigue time course similar to that of untreated wild-type (Fig. 3, A and B) . In fact, the tetanic force of S1P 3 -null EDL fibers at the last tetanus was 0.22 Ϯ 0.03 P 0 without S1P and 0.44 Ϯ 0.07 P 0 in the presence of the lipid, a value very close to that of untreated wild-type (0.42 Ϯ 0.09 P 0 ). Moreover, after 2 min of resting, in the presence of S1P, the tetanic force of S1P 3 -null EDL moved from 0.44 Ϯ 0.07 P 0 (last fatiguing tetanus) to about 0.67 Ϯ 0.10 P 0 , with the recovery force curve almost identical to that of the wild-type (Fig. 3, A and B) .
To better evaluate the tension decrease during fatigue, we measured the fiber stiffness-tension relation during fatigue and tension rise in FDB fibers that are a more reliable, reproducible, and less variable mechanical model than EDL muscle fibers, in particular for the stiffness measurements (45) . In FDB fibers, the fatigue time course showed, more clearly than in EDL fibers, a first rapid decay and a second slower decrease of tension (43) . As in the S1P 3 -null EDL, in the absence of S1P 3 , the FDB fibers showed a higher fatigability than wild-type (Fig. 4A) . At the end of the fatigue protocol, the force of FDB fibers decreased to 0.66 Ϯ 0.03 P 0 in wild-type and to 0.49 Ϯ typical twitch tension curves of WT and S1P3-null EDL. B: typical tetanic tension curves of WT and S1P3-null EDL. C: mean twitch (Pt) and tetanic (P0) tensions of WT and S1P3-null EDL. D: force/ frequency curves of WT (OE) and S1P3-null (shaded circles) EDL. Force is expressed relative to the maximum tetanic force. Data are reported as means Ϯ SE. In each group, 4 experiments were carried out. *P Ͻ 0.05 compared with WT.
0.02 P 0 in S1P 3 -null fibers. When one compares the EDL and FDB fatigue profiles (Figs. 3 and 4) , it is clear that FDB, having a more oxidative phenotype, is basically more resistant to fatigue than EDL. As in the EDL, S1P supplementation did not influence force decrease in fatigued wild-type fibers (Fig.  4A) . On the contrary, the higher fatigability of S1P 3 -null FDB fibers was significantly reduced by S1P supplementation (Fig.  4A) , with the final tension value (0.63 Ϯ 0.03 P 0 ) similar to that of untreated wild-type fibers (0.66 Ϯ 0.03 P 0 ). As in EDL, S1P treatment did not make the null fibers more resistant to the early fatigue, but it decreased the loss of tension during the later phase (Figs. 3B and 4A ). In FDB, the recovery of wild-type and S1P 3 -null fibers, without or with S1P supplementation, was similar, reaching a high value of force in a few minutes, then slowly enduring. At the end of the recovery protocol, tetanic force reached 0.97 Ϯ 0.02 of the prefatigue value in wild-type fibers, 0.98 Ϯ 0.01 in S1P-treated wild-type fibers, 0.92 Ϯ 0.03 in S1P 3 -null fibers, and 0.94 Ϯ 0.02 in S1P-treated S1P 3 -null fibers. It is worth noting that, in the presence of S1P, the recovery seems improved; in S1P 3 -null fibers, as in the untreated wild-type and in the wild-type fibers, recovery reached the prefatigue tension value within the first minutes (Fig. 4A) .
As in EDL (Fig. 3C) , the stiffness of S1P 3 -null FDB fibers decreased in proportion to tension, and S1P supplementation decreased stiffness in the later phase of fatigue (Fig. 4B) . The data of Fig. 4B were also plotted as a stiffness-tension relation and compared with those obtained on the same fibers during tetanus rise, a condition in which the force development is considered proportional to crossbridge number (Fig. 4C) . The stiffness-tension relation during the rise was not linear and deviated from the direct proportionality (showed by the dashed line) attributable to the myofilament and tendon stiffness presence (3, 9, 43, 45) . In S1P 3 -null fibers, treated or not with S1P, the stiffness-tension relationship during fatigue had a more pronounced downward curvature and deviated even more from linearity so that, especially at high tension, fiber stiffness was greater than during the tetanus rise.
Denervation atrophy. We previously reported that denervation of rat soleus muscle modifies the expression of S1P receptors, causing a decrease of both S1P 1 and S1P 3 (69) . The analysis of S1P receptors (S1P 1-3 ) transcripts in 14-day-denervated EDL muscle of wild-type mice confirms an overall decrease of all S1P receptors after denervation. In S1P 3 -null mice, denervation caused a significant decrease of both S1P 1 and S1P 2 receptors (Fig. 5) .
To examine the possible role of S1P 3 in the regulation of muscle mass, we analyzed the effects of muscle denervation in S1P 3 -null transgenic mice. We measured the extent of muscle atrophy as the percentage change of the mean CSA of fibers from 7-and 14-day-denervated EDL with respect to fibers from the contralateral innervated muscle. Denervation caused a progressive atrophy in wild-type EDL, whose mean fiber CSA was reduced by 15.3% after 7 days and 41.2% after 14 days. In S1P 3 -null mice, denervation produced a smaller atrophy in EDL fibers, whose mean CSA was in fact reduced by 9.7% at 7 days and 26.8% (P Ͻ 0.05) at 14 days (Fig. 6, A-C) . A: tension development during fatigue and recovery of EDL fibers from WT mice (n ϭ 8) without and with S1P supplementation (1 M, ). B: tension development during fatigue and recovery of EDL fibers from S1P3-null mice (n ϭ 5) without and with 1 M S1P supplementation (ϩ S1P, ). *P Ͻ 0.05 compared with the corresponding WT values of the untreated muscles shown in A; a P Ͻ 0.05 compared with untreated S1P3-null fibers. C: tension and stiffness drop during fatigue in WT (n ϭ 5) and S1P3-null (n ϭ 4) EDL fibers. Stiffness and tension are expressed relative to their plateau value before fatigue. For fatigue and recovery protocols, see METH-ODS. Data are reported as means Ϯ SE.
Denervation is known to cause a fast-to-slow transformation in wild-type EDL, with the progressive increase of both type 1 and type 2A MyHC isoforms and the decrease of type 2B MyHC (22, 40) . Similarly, denervation induced a comparable transformation to S1P 3 -null EDL, with the progressive increase of type 1 MyHC isoform and the decrease of type 2B MyHC, whereas the proportion of type 2A MyHC was not different compared with the innervated muscle (Fig. 6D) .
Atrophy-related genes. Muscle atrophy is the consequence of the imbalance between protein synthesis and degradation (35) . To evaluate whether the smaller atrophy induced by denervation to the S1P 3 -null EDL was associated with a different activation of atrophy-related genes, we analyzed the expression level of atrophy-associated E3 ligases MuRF1 and atrogin-1. As expected (4), expression of MuRF1 progressively increased during denervation of wild-type and S1P 3 -null EDL (Fig. 7A) . Eventually, 14 days after denervation, the expression level of MuRF1 was similarly increased in wildtype and S1P 3 -null EDL (2.5 and 2.4 times, respectively). The analysis of the other E3 ligase, atrogin-1, shows that denervation did not increase the expression of atrogin-1 both in wild-type and S1P 3 -null EDL (Fig. 7B) .
In the early phases of denervation, the expression of E3 ubiquitin ligases is modulated by transcription factor myogenin (63) . In innervated EDL, the basal protein expression level of myogenin was significantly higher in the S1P 3 -null than in wild-type EDL (Fig. 7C) . As expected, denervation upregulates the expression of myogenin. Eventually, 14 days after denervation, the expression level of myogenin was increased 2.7 and 2.3 times in wild-type and S1P 3 -null EDL, respectively.
The FoxO family of transcription factors also plays a critical role in the atrophy program. Because FoxO is downstream of the insulin-Akt-mTOR pathway (55), we have evaluated expression levels of these proteins during denervation. The extent of activated Akt (P-Akt) progressively increased in both denervated wild-type and transgenic EDL, apparently more slowly in the S1P 3 -null EDL. However, the ratio between P-Akt and total Akt did not change appreciably during denervation of both wild-type and S1P 3 -null EDL (Fig. 7E) . The analysis of P-FoxO3 vs. FoxO3 protein ratio shows no major changes in wild-type and S1P 3 -null EDL muscle during denervation (Fig. 7D) .
Denervation is associated with, not only the progressive reduction of muscle mass, but also the variation of mitochondrial content, either as an adaptation to the reduced fiber volume and energy request (67) and/or as an event concurring to the atrophy program (5, 6). The higher SDH staining and level of total cytochrome c indicate that S1P 3 -null EDL muscle contains more mitochondria than wild-type. We thus investigated the expression of PGC-1␣, a key regulator of mitochondria biogenesis (34) . Basal PGC-1␣ expression level was higher in innervated S1P 3 -null EDL compared with wild-type (Fig. 8A) . Denervation of wild-type and S1P 3 -null EDL caused no major changes of PGC-1␣ protein level. Nevertheless, PGC-1␣ protein level was significantly higher in 7-and 14-day-denervated S1P 3 -null EDL compared with the respective values of wild-type EDL (Fig. 8A) .
Recently, it has been proposed that, in the denervated muscle, cytoplasmic cytochrome c is released from fragmented mitochondria to start apoptosis (48, 60) . A first step is activation of caspase-3 that, among other targets, seems to cleave myofibrillar actin to generate a 14-kDa fragment, which is then ubiquitinated and degraded (16) . To investigate this occurrence, we measured the cytoplasmic cytochrome c level in TA muscle instead of EDL because of its larger mass. Our results did not show a clear increase of cytosolic cytochrome c level after denervation in wild-type and S1P 3 -null TA muscle. However, it is worth reporting that cytosolic cytochrome c slightly increased in the denervated wild-type TA (from 3.31 Ϯ 0.71 to 4.37 Ϯ 1.13 a.u., ϩ32%, n ϭ 6) and slightly decreased in the S1P 3 -null muscle (from 3.72 Ϯ 0.6 to 2.93 Ϯ 0.93 a.u., Ϫ21%, n ϭ 7). We then measured the amount of the 14-kDa actin fragment possibly generated by caspase-3 activity. Denerva- tension development during fatigue and recovery of FDB muscle fibers from WT (OE, n ϭ 8) and S1P3-null mice (, n ϭ 4). The effects of 1 M S1P supplementation (ϩ S1P) were measured in WT (, n ϭ 8) and S1P3-null fibers (', n ϭ 4). *P Ͻ 0.05 compared with the corresponding WT values of the untreated fibers. B: effects of S1P on tension (circles) and stiffness (squares) drop during fatigue in S1P3-null (n ϭ 4) FDB fibers. Tension data are the same as in A. C: comparison of the stiffness-tension relations during fatigue and tetanic tension rise (TTR). Stiffness and tension are expressed relative to their plateau value before fatigue. The dashed straight line indicates the direct proportionality between tension and stiffness. Measurements on the TTR (inverted triangles) and fatigue (triangles) were made on the same fibers; therefore, the absolute fiber stiffness at plateau was the same in both cases. For fatigue and recovery protocols, see METHODS. Data are reported as means Ϯ SE.
tion induced an increase of 14-kDa actin fragment in wild-type but had no effects on S1P 3 -null EDL (Fig. 8B) . Denervation stimulates autophagic signaling pathways in muscle (46) . To evaluate in the denervated muscle the possible role of S1P signaling in the activation of autophagy gene expression and flux, we measured the amount of p62 protein, a protein involved in the recognition of autophagy substrates, and the LC3-II/LC3-I ratio, which is important in autophagosome formation (55) . Denervation induced a marked increase of p62 protein both in wild-type and S1P 3 -null EDL, with an apparent progressive increase in wild-type and a late strong increase in the transgenic muscle (Fig. 8C) . Similarly, denervation caused a progressive and marked increase of the LC3-II/LC3-I ratio in wild-type EDL muscle, whereas the increase was evident only after 7 days in the S1P 3 -null muscle (Fig. 8D) .
DISCUSSION
This work investigated the role of S1P 3 in skeletal muscle. We utilized the S1P 3 -null mouse model to determine the . Expression of S1P receptors transcripts in WT and S1P3-null EDL muscle after 14 days of denervation. Expression of S1P receptors in each muscle was measured by real-time PCR and compared with that in WT innervated muscles. ND, not detected. Results are expressed as fold changes according to the 2 -⌬⌬Ct method, utilizing murine S1P1, S1P2, or S1P3 genes in WT innervated EDL muscle as calibrator. Data are reported as means Ϯ SE of 3 independent experiments performed in triplicate. WT and S1P3-null data from innervated muscles are the same as in Fig. 1D . *P Ͻ 0.05 and **P Ͻ 0.01 compared with innervated muscles. WT S1P 3 -null Fig. 6 . Effects of denervation on WT and S1P3-null EDL muscle. A: laminin staining of innervated and 14-denervated EDL muscle from WT and S1P3-null mouse. Bar ϭ 50 m. B: changes of muscle fiber CSA in EDL muscle. The comparison was done between each denervated muscle and its contralateral innervated muscle. In each group, 4 -6 experiments were carried out. Data are reported as means Ϯ SE. *P Ͻ 0.05 compared with WT. C: mean CSA distribution of 14-day-denervated EDL from WT and S1P3-null mice. D: changes of MyHC isoform composition in denervated EDL from WT and S1P3-null mice. Data are reported as means Ϯ SE. In each group, 4 -6 experiments were carried out. *P Ͻ 0.05, compared with the innervated muscle.
effects of receptor ablation on morphological and physiological characteristics of EDL muscle. The analysis of EDL muscle showed no overt muscle mass and morphological differences between wild-type and S1P 3 -null mice. Minor differences were related to the lower twitch tension and a larger proportion type 1 MyHC and mitochondria in S1P 3 -null EDL. However, two main differences emerged: 1) the S1P 3 -null EDL is more fatigable than wild-type; 2) during denervation, the S1P 3 -null EDL is less prone to atrophy than wild-type. Typically, force decline during development of fatigue shows a first phase in which force rapidly declines followed by a second slower phase (2, 45) . Our previous data obtained in FDB fibers (43, 45) showed that the initial force decline occurred without great reduction of the number of attached crossbridges (or fiber stiffness), but it was attributed to a reduction of the average force per attached crossbridge. In the second phase, the force decrease was accompanied by a proportional stiffness decline and therefore attributable to the reduction of attached crossbridge number. As during the initial force decline, tetanic [Ca 2ϩ ] i is not reduced but rather increased (66) ; the first loss of force has been attributed to a fast direct inhibitory effect of the increase of the [P i ] i that pushes the crossbridge into a low-force-generating state (7, 10, 49) . On the contrary, the later force decline is attributed to a reduction of Ca 2ϩ release from the sarcoplasmic reticulum (20) and/or a reduced myofilament Ca 2ϩ sensitivity attributable to high [P i ] i and/or higher production of reactive oxygen and nitrogen species (30) . Present results show that, in the absence of S1P 3 , EDL fibers fatigue largely more than wild-type. Tension and stiffness data show that, as in FDB (43, 45) , in EDL fibers it is also possible to distinguish two different phases during fatigue. In the initial phase, force of wild-type and S1P 3 -null fibers declined more than stiffness, implying on both cases a similar reduced force per attached crossbridge. On the contrary, the average time course of stiffness during late fatigue decreased similarly to tension both in wild-type and S1P 3 -null fibers (Figs. 3C and 4B), indicating a proportional reduction of crossbridge number. To further inspect the two different mechanisms responsible for the fatigue, we analyzed the stiffness-tension relation in S1P 3 -null FDB fibers treated or not with S1P. If tension loss during fatigue is due exclusively to the reduction of attached crossbridge number, the stiffness-tension relation during fatigue should be exactly the same as during the tetanus rise (3, 9, 43, 45) . On the contrary, our data show that, during fatigue, the relation has more pronounced downward curvature and deviates even more from linearity so that fiber stiffness is greater than during the tetanus rise. Because filament and tendon stiffness are the same in both conditions, this means that, at any given force, to justify the greater fiber stiffness, there must be more attached crossbridges during fatigue than during the tetanus rise, which means that each fatigued crossbridge generates less average force. Both in S1P 3 -null treated or untreated fibers, this effect is probably due to the high [P i ] i . The tension stiffness relation in FDB fibers indicates a reduction in crossbridge number in the second phase, supporting the EDL results.
This evidence suggests that the higher drop of tension of S1P 3 -null fibers compared with wild-type could be related to a larger reduction of calcium availability. Although we did not perform direct measurements of intracellular calcium, this possibility is consistent with the demonstrated involvement of S1P 3 in the S1P-induced increase of intracellular calcium in skeletal (50) and smooth muscle cells (21) , suggesting that S1P 3 provides the extra calcium needed to attenuate fatigue in wild-type EDL or FDB fibers. In wild-type EDL, two main S1P receptors, S1P 1 and S1P 3 , are expressed at the surface and in the T tubules of muscle fibers (13) . The localization in the T tubules, i.e., the site of excitation-contraction coupling, validates a potential role in contractility of the two S1P receptors. However, we cannot exclude the contribution of possible changes of calcium sensitivity of myofilaments and/or altered fiber metabolites. Similarly to fatigue, the initial fast recovery is likely due to a return to normal levels of [P i ] i (43, 68) , whereas the late force recovery depends on the slower return to normal condition of calcium release and/or myofilament calcium sensitivity (43) . The smaller recovery of the EDL S1P 3 -null with respect to wild-type fibers is probably related to the dramatically higher drop of force at the end of the fatigue protocol.
We also examined the effects of supplemented S1P on fatigue responses of wild-type and S1P 3 -null EDL fiber bundles. In contrast with previous data (11), S1P supplementation did not ameliorate fatigue development and recovery of wildtype EDL. The divergence could be due to different experimental protocols (whole muscle vs. fiber bundles, frequency stimulation and temperature, 30 vs. 24°C) and/or the different mice strain utilized in the experiments (CD1 vs. C57BL/6J). Notably, S1P supplementation strongly reduced the loss of force in the second phase of fatigue of S1P 3 -null EDL, apparently indicating that exogenous S1P stimulates an increased amount of calcium release from the sarcoplasmic reticulum, possibly operated by S1P 1 . However, stimulation of S1P 1 is known to inhibit the release of calcium (29) . On the other hand, overstimulation of S1P receptors, and in particular of S1P 1 , is known to cause internalization of the receptor followed by either ubiquitin-directed degradation of the protein, resulting in the termination of receptor signaling, or alternatively trafficking of the receptor and activation of intracellular signals (65) . Thus internalization of S1P 1 could abrogate its putative negative action on fatigue, making the muscle less fatigable. Future work is necessary to discriminate between the possible functions of S1P 1 receptor in muscle fatigue.
Finally, our results also show that twitch tension amplitude is reduced in the S1P 3 -null EDL, without changes in the time-to-peak and half-relaxation times. The amplitude of twitch tension is essentially associated with the rate and amount of calcium released and reaccumulated from and into the sarcoplasmic reticulum. Also this result demonstrates that, in the absence of S1P 3 , the excitation-contraction coupling process is perturbed. It is worth noting that S1P 3 -null EDL has a slightly higher content of type 1 MyHC (up to 6%), which could contribute to reduce the amplitude of twitch tension. However, we exclude this possibility because contraction and half-relaxation times as well as the maximal rate of rise of tetanic tension were unmodified (data not shown). Moreover, the higher content of type 1 MyHC and of mitochondria in S1P 3 -null EDL did not compensate the effects on fatigue caused by the absence of the receptor.
We have recently demonstrated that S1P 1 and S1P 3 receptors are localized both in the T tubules and in the sarcolemma (13) . Here, we propose that the different localization of these receptors could serve two different functional roles. As indicated above, S1P receptors in the T tubules are probably involved in the modulation of contractility. We hypothesize that sarcolemmal S1P receptors could modulate distinct signaling pathways, such as that regulating muscle mass.
Past studies demonstrated that S1P signaling exerts a trophic role in rat soleus denervation atrophy. In fact, boosting or decreasing circulating S1P ameliorated or worsened, respectively, denervation atrophy (69) . Moreover, denervation downregulated the expression of S1P 1 and S1P 3 receptors, which could contribute to muscle atrophy by reducing the trophic influence of S1P. Present results show that, in the absence of S1P 3 , in denervated EDL, atrophy is substantially less than in wild-type muscle. In wild-type EDL, S1P 1 and S1P 3 may contribute to regulate muscle mass, either in the same direction and/or by balancing opposite actions. However, the data indicate that the absence of S1P 3 is beneficial for denervated EDL and attenuates the atrophy program, suggesting that signaling pathways downstream of S1P 3 , implicated in the onset and development of atrophy, are less active in the S1P 3 -null muscle than in wild-type.
The absence of S1P 3 has distinct effects on the expression of key proteins involved in the muscle atrophy program as a consequence of denervation. First, unexpectedly, despite the reduced atrophy, the protein level of the E3 ligase MuRF1 similarly increased in denervated wild-type and S1P 3 -null EDL and increased more in the 14-day denervated S1P 3 -null EDL than in the wild-type. Despite the known increase of atrogin-1 mRNA in the early phases of muscle atrophy (31) , our data show that, at 7 and 14 days after denervation, atrogin-1 protein level is similar to that of innervated muscles both in wild-type and S1P 3 -null EDL. Thus, apparently, the smaller atrophy of denervated S1P 3 -null EDL does not seem to involve these basic atrophy players.
Compared with the denervated wild-type, no difference was observed in the S1P 3 -null EDL in regard to Akt, myogenin, and FoxO3 protein levels, known key players in denervation atrophy. Of note, although myogenin expression, as expected (63), increased upon denervation similarly in wild-type and S1P 3 -null EDL, the basal level of myogenin was higher in S1P 3 -null EDL compared with wild-type.
Consistent with the higher content of mitochondria, the basal expression of PGC-1␣ protein, a key regulator of mitochondria biogenesis (34) , is higher in innervated S1P 3 -null EDL compared with wild-type. Recently, it has been demonstrated that EDL atrophy is largely reduced in transgenic mice overexpressing PGC-1␣ (6, 51, 56, 64) . Therefore, the higher basal level of PGC-1␣ in the S1P 3 -null EDL could provide an explanation for why the muscle is, at least partly, protected from denervation atrophy. However, further research is required to understand the actual role of PGC-1␣ in muscle atrophy.
Apoptotic and autophagic signaling pathways are activated in muscle denervation atrophy to adequate myonuclear and mitochondrial content to the reduced fiber size (47) . Moreover, mitochondria also undergo a partial fragmentation that liberates cytochrome c into the cytoplasm (1). The release of cytochrome c into the cytoplasm is known to activate caspase 9 and 3 (48, 60), which seems involved in the initial fragmentation of myofibrillar actin, a necessary step for the subsequent actin degradation by E3 ligases (16) . Our data confirm the increase of cytoplasmic cytochrome c in the denervated wildtype TA but show a small decrease in the S1P 3 -null TA, suggestive of a different trend between the two muscles. Moreover, we confirm the increase of 14-kDa actin fragment during denervation of wild-type EDL. Conversely, the level of the 14-kDa actin fragment does not change during denervation of S1P 3 -null EDL. This finding suggests that, in S1P 3 -null EDL, MuRF1, though elevated, is not able to tackle the dismantling of myofibrils as in wild-type and could provide an explanation for the smaller atrophy of the transgenic muscle.
During denervation, autophagy and autophagy-related genes (i.e., LC3-II, p62, Beclin1) are upregulated, with the extra LC3-II preferentially associated to mitochondria (47) . We here confirm that LC3-II levels progressively increase in denervated wild-type EDL, whereas, in S1P 3 -null EDL, autophagy seems to progress less precisely, suggesting that the absence of S1P 3 perturbs autophagy.
In conclusion, we propose that S1P 3 plays a role in attenuating the development of EDL muscle fatigue as well as in controlling the mass of the denervated fast-twitch muscle. We propose that the first action is due to the T-tubule-associated receptor, whereas the second is to be ascribed to the sarcolemmal one. The protective role against fatigue is most likely associated to a modulatory role of S1P 3 in EC coupling and eventually in intracellular calcium mobilization. The role of S1P 3 in controlling muscle mass and the mechanisms involved appear to be more complex. The finding that S1P 3 ablation has a protective role against denervation-induced muscle atrophy suggests that this receptor is implicated in autophagy. 
